Cann Global Logo
AU0000038085
A2PDNF
CGB.AX

Cann Global

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last year, Cann Global had revenue of €370.2K and net profit of -€5.41M
(EUR) 2022
YoY
Revenue 370.2K 60.66%
Gross profit -51.48K 124.99%
Net profit -5.41M 85.10%
EBITDA -2.34M 11.93%

Fundamentals

Metric Value
Market capitalization
€3.42M
Number of shares
267.37M
52-week high/low
€0.0177 - €0.0104
Dividends No
Beta
0.96
P/E ratio
-0.63
PEG ratio
-0.01
P/B ratio
0.50
P/S ratio
9.98

Company profile

Cann Global Limited operates in medicinal cannabis and hemp food industries in Australia and internationally. The company operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. It grows and cultivates hemp and medical cannabis products; and provides plant-based food and skincare products. The company also engages in the exploration and development of bauxite. In addition, it holds interests in the South Johnstone Project located in Queensland. The company was formerly known as Queensland Bauxite Limited and changed its name to Cann Global Limited in January 2019. Cann Global Limited was incorporated in 2007 and is based in Sydney, Australia.

Name
Cann Global
CEO
Sholom Dovber Feldman
Headquarters Sydney, nsw
Australia
Website
IPO
01/14/2019

Ticker symbols

Exchange Symbol
Australian Securities Exchange Ltd
CGB.AX
🍪

Parqet  uses cookies. Learn more